Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
26 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
INNOVATIVE PHARMACEUTICS from Gent, company number BE0883574582, closed financial year 2025 with a result of € 77,375 after tax. For that financial year INNOVATIVE PHARMACEUTICS recorded a gross margin of € 21,160 and equity of € 2.2 million. Compared with financial year 2024, the result moved from € 98,559 to € 77,375. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 2.2 million
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 77,375
▼ 21% vs 2024
Profit after tax over the fiscal year.
€ 1.1 million
▼ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.2 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 5,929
▲ 172% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,738
▼ 43% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 23,963 | € 75,227 | € 67,696 | € 21,160 | ▼ 69% |
| Profit after taxes | € 17,407 | € 36,478 | € 98,559 | € 77,375 | ▼ 21% |
| Equity | € 2,011,859 | € 2,048,337 | € 2,146,896 | € 2,224,271 | ▲ 4% |
| Total debts | € 45,909 | € 13,741 | € 15,757 | € 13,667 | ▼ 13% |
| Cash | € 1,445,338 | € 1,346,171 | € 1,225,064 | € 1,057,933 | ▼ 14% |
| Retained profit | € 1,981,859 | € 2,018,337 | € 2,116,896 | € 2,194,271 | ▲ 4% |
| Balance sheet total | € 2,057,768 | € 2,062,078 | € 2,164,918 | € 2,237,938 | ▲ 3% |
Key figures of INNOVATIVE PHARMACEUTICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INNOVATIVE PHARMACEUTICS?
What happened at INNOVATIVE PHARMACEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 77,375 (▼ 21% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Gent. KBO
In short
From € 17,407 profit in 2022 to € 77,375 profit in 2025.
Paid € 93,151 in corporate taxes since 2022.
Best year ever: 2024, with € 98,559 profit.
A new publication or filing at INNOVATIVE PHARMACEUTICS? We notify you, reason included.
Follow INNOVATIVE PHARMACEUTICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 82
9052 Gent
Technologiepark-Zwijnaarde 3
9052 Gent
Active since 13 September 2006
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
All companies at this address →CONTREL EUROPE
€ 250,724 gross margin · 2025
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
€ 1.4 million gross margin · 2025
VP VENTURES
€ -1,670 gross margin · 2025
SENSNET
Inbiose
€ 6.3 million revenue · 2025
+21 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.574.582
- VAT number
- BE 0883.574.582
- Registered office
- Technologiepark-Zwijnaarde 82, 9052 Gent
- Names & denominations
- INNOVATIVE PHARMACEUTICS · INNOCEUTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 September 2006
- Peppol
- Active · Active since 27 Dec 2025
- Activities · NACE
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen
Handelsbemiddeling in voedings- en genotmiddelen